Israeli-Developed Breakthrough Cancer Drug Receives FDA Approval | Algemeiner
JNS.org – Kite Pharma, founded by Israeli-American professor Arie Belldegrun in 2009, announced that the US Food and Drug Administration (FDA) has granted regular approval for its cancer treatment, Yescarta.
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.